osmolality has been known to increase ANP release. However, its physiological role in the regulation of atrial myocytic ANP release and the mechanism by which hyperosmolality increases ANP release are to be defined. The purpose of the present study was to define these questions. Experiments were performed in perfused beating rabbit atria. Hyperosmolality increased atrial ANP release, cAMP efflux, and atrial dynamics in a concentration-dependent manner. The osmolality threshold for the increase in ANP release was as low as 10 mosmol/ kgH2O (ϳ3%) above the basal levels (1.55 Ϯ 1. 71, 17.19 Ϯ 3.11, 23.15 Ϯ 5.49, 54.04 Ϯ 11.98, and 62.00 Ϯ 13.48% for 10, 20, 30, 60, and 100 mM mannitol, respectively; all P Ͻ 0.01). Blockade of sarcolemmal L-type Ca 2ϩ channel activity, which increased ANP release, attenuated hyperosmolality-induced increases in ANP release (Ϫ13.58 Ϯ 4.68% vs. 62.00 Ϯ 13.48%, P Ͻ 0.001) and cAMP efflux but not atrial dynamics. Blockade of the Ca 2ϩ release from the sarcoplasmic reticulum, which increased ANP release, attenuated hyperosmolality-induced increases in ANP release (13.44 Ϯ 7.47% vs. 62.00 Ϯ 13.48%, P Ͻ 0.01) and dynamics but not cAMP efflux. Blockades of Na ϩ -K ϩ -2Cl Ϫ cotransporter, Na ϩ /H ϩ exchanger, and Na ϩ /Ca 2ϩ exchanger had no effect on hyperosmolality-induced increase in ANP release. The present study suggests that hyperosmolality regulates atrial myocytic ANP release and that the mechanism by which hyperosmolality activates ANP release is closely related to the cross-talk between the sarcolemmal L-type Ca 2ϩ channel activity and sarcoplasmic reticulum Ca 2ϩ release, possibly inactivation of the L-type Ca 2ϩ channels.atrial natriuretic peptide; L-type calcium channels; sarcoplasmic reticulum calcium release; hyperosmolality ACUTE INCREASE in osmolality increases ANP release in vitro and in vivo. Hyperosmolality accentuates ANP release in rat atrial block (4, 32), atrial slice (48), dispersed atrial myocytes (19), and beating or nonbeating atria (40). In humans, moderate or marked acute hyperglycemia increases plasma levels of ANP (5, 10, 31). Some of these reports show that hyperosmolality by about 9 -13% of basal levels accentuates ANP release (4, 19). Although the mechanism by which hyperglycemia increases plasma levels of ANP is difficult to differentiate from its effect induced by hypervolemia, these findings suggest that hyperosmolality may be a stimulant to increase atrial ANP release. Hypertonicity by high extracellular osmolality results in a shrinkage of cardiomyocytes (14). Hyperosmolality has been known to induce an activation of NaϪ1 cotransporter (NKCC) in rabbit ventricular myocytes (14) The change in atrial volume has been considered the most important physiological factor in the regulation of ANP release (8,13,27). There have also been reported various modulating factors for ANP release (35). Ca 2ϩ has been known to have diverse effects on atrial ANP release, i.e., an increase or a decrease in ANP release. Many reports indicate that increase in Ca 2ϩ influx ...